Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized clopidogrel use after PCI based on CYP2C19 genotype
ChiCTR-TRC-11001807Phase 4Completed
- Sponsor
- First Affiliated Hospital of Xinjiang Medical University
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of clopidogrel in coronary arteriosclerosis (2 arms), sponsored by First Affiliated Hospital of Xinjiang Medical University. Primary endpoints: Platelet aggregation, Incidence of bleeding and 2 more. Started Jan 2011; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-11001807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001807.